56 related articles for article (PubMed ID: 23466605)
1. Design, synthesis and biological evaluation of bakuchiol derivatives as multi-target agents for the treatment of Alzheimer's disease.
Zhang XQ; Xiang YN; Qin T; Zou JP; Guo QW; Han ST; Zhang ZY; Liu WW; Ding G; Dong JQ; Shi DH
Fitoterapia; 2024 Apr; 174():105867. PubMed ID: 38382891
[TBL] [Abstract][Full Text] [Related]
2. The Cholinergic Selectivity of FDA-Approved and Metabolite Compounds Examined with Molecular-Docking-Based Virtual Screening.
Gambardella MD; Wang Y; Pang J
Molecules; 2024 May; 29(10):. PubMed ID: 38792196
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Biological Evaluation, and In Silico Studies of New Acetylcholinesterase Inhibitors Based on Quinoxaline Scaffold.
Suwanhom P; Saetang J; Khongkow P; Nualnoi T; Tipmanee V; Lomlim L
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443482
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
Soyer Z; Uysal S; Parlar S; Tarikogullari Dogan AH; Alptuzun V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):13-19. PubMed ID: 27766908
[TBL] [Abstract][Full Text] [Related]
5. Dual binding site and selective acetylcholinesterase inhibitors derived from integrated pharmacophore models and sequential virtual screening.
Gupta S; Mohan CG
Biomed Res Int; 2014; 2014():291214. PubMed ID: 25050335
[TBL] [Abstract][Full Text] [Related]
6. Sequential Contrastive and Deep Learning Models to Identify Selective Butyrylcholinesterase Inhibitors.
Ozalp MK; Vignaux PA; Puhl AC; Lane TR; Urbina F; Ekins S
J Chem Inf Model; 2024 Apr; 64(8):3161-3172. PubMed ID: 38532612
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Structure-Activity Relationship Modeling of Pea Protein-Derived Acetylcholinesterase and Butyrylcholinesterase Inhibitory Peptides.
Asen ND; Udenigwe CC; Aluko RE
J Agric Food Chem; 2023 Nov; 71(43):16323-16330. PubMed ID: 37856319
[TBL] [Abstract][Full Text] [Related]
8. Anticholinesterase activity of plastoquinones from Sargassum sagamianum: lead compounds for Alzheimer's disease therapy.
Choi BW; Ryu G; Park SH; Kim ES; Shin J; Roh SS; Shin HC; Lee BH
Phytother Res; 2007 May; 21(5):423-6. PubMed ID: 17236179
[TBL] [Abstract][Full Text] [Related]
9. Active site gating and substrate specificity of butyrylcholinesterase and acetylcholinesterase: insights from molecular dynamics simulations.
Fang L; Pan Y; Muzyka JL; Zhan CG
J Phys Chem B; 2011 Jul; 115(27):8797-805. PubMed ID: 21682268
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Silico Kinetic Studies of Patented 1,7-diEthyl and 1,7-diMethyl Aminoalkanol Derivatives as New Inhibitors of Acetylcholinesterase.
Grodner B; Napiórkowska M; Pisklak DM
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008697
[TBL] [Abstract][Full Text] [Related]
11. 1,3-substituted imidazolidine-2,4,5-triones: synthesis and inhibition of cholinergic enzymes.
Pejchal V; Stepankova S; Padelkova Z; Imramovsky A; Jampilek J
Molecules; 2011 Sep; 16(9):7565-82. PubMed ID: 21894089
[TBL] [Abstract][Full Text] [Related]
12. Structural, computational and
N Hegde V; J S S; B S C; Benedict Leoma M; N K L
J Biomol Struct Dyn; 2024 Jun; 42(9):4619-4643. PubMed ID: 37418246
[TBL] [Abstract][Full Text] [Related]
13. Applications of integrated data mining methods to exploring natural product space for acetylcholinesterase inhibitors.
Schuster D; Kern L; Hristozov DP; Terfloth L; Bienfait B; Laggner C; Kirchmair J; Grienke U; Wolber G; Langer T; Stuppner H; Gasteiger J; Rollinger JM
Comb Chem High Throughput Screen; 2010 Jan; 13(1):54-66. PubMed ID: 20214575
[TBL] [Abstract][Full Text] [Related]
14. Peripheral site acetylcholinesterase inhibitors targeting both inflammation and cholinergic dysfunction.
Young S; Fabio K; Guillon C; Mohanta P; Halton TA; Heck DE; Flowers RA; Laskin JD; Heindel ND
Bioorg Med Chem Lett; 2010 May; 20(9):2987-90. PubMed ID: 20347302
[TBL] [Abstract][Full Text] [Related]
15. Diverse Pharmacological Potential of Pyridazine Analogs against Various Diseases.
Alsaiari AA; Almehmadi MM; Asif M
Med Chem; 2024; 20(3):245-267. PubMed ID: 37711126
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of 28-O-Caffeoyl Betulin (B-CA) on the Cerebral Cortex of Ischemic Rats Revealed by a NMR-Based Metabolomics Analysis.
Liu X; Ruan Z; Shao XC; Feng HX; Wu L; Wang W; Wang HM; Mu HY; Zhang RJ; Zhao WM; Zhang HY; Zhang NX
Neurochem Res; 2021 Mar; 46(3):686-698. PubMed ID: 33389470
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors.
Xing W; Fu Y; Shi Z; Lu D; Zhang H; Hu Y
Eur J Med Chem; 2013 May; 63():95-103. PubMed ID: 23466605
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
Utku S; Gökçe M; Orhan I; Sahin MF
Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
